|
ZNF738 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.07470000255373E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.44539999999716E-05 |
| Normal-vs-Stage2 |
4.84219997431978E-10 |
| Normal-vs-Stage3 |
3.66209995661393E-09 |
| Normal-vs-Stage4 |
1.70359999995817E-07 |
| Stage1-vs-Stage2 |
2.167300E-04 |
| Stage1-vs-Stage3 |
2.997200E-03 |
| Stage1-vs-Stage4 |
2.410100E-02 |
| Stage2-vs-Stage3 |
3.272200E-01 |
| Stage2-vs-Stage4 |
2.299400E-01 |
| Stage3-vs-Stage4 |
7.956600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.59359999973852E-07 |
| Normal-vs-AfricanAmerican |
1.596560E-01 |
| Normal-vs-Asian |
1.866380E-02 |
| Caucasian-vs-AfricanAmerican |
4.529400E-01 |
| Caucasian-vs-Asian |
8.186500E-02 |
| AfricanAmerican-vs-Asian |
8.994600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.99860000000119E-05 |
| Normal-vs-Female |
5.20339999976471E-08 |
| Male-vs-Female |
2.879000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.427100E-04 |
| Normal-vs-Age(41-60Yrs) |
1.260399999925E-07 |
| Normal-vs-Age(61-80Yrs) |
2.55019999562123E-08 |
| Normal-vs-Age(81-100Yrs) |
3.859200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.655300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.996000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.892400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.836200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.935600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.486400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.134600E-01 |
| Classical-VS-Follicular |
7.842600E-03 |
| Classical-VS-Other |
5.000000E-01 |
| Classical-VS-Normal |
7.54920000000103E-05 |
| Tall-VS-Follicular |
1.647640E-01 |
| Tall-VS-Other |
4.839800E-01 |
| Tall-VS-Normal |
2.597000E-04 |
| Follicular-VS-Other |
1.358800E-01 |
| Follicular-VS-Normal |
6.07029999599717E-08 |
| Other-VS-Normal |
3.193000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.68319999552347E-09 |
| Normal-vs-N1 |
9.584500E-03 |
| N0-vs-N1 |
3.729500E-02 |
|
|
